🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to explore Lab-in-the-Loop efficiencies with Generate:Biomedicines ’s Mike Nally & Jason Silvers—redefining drug discovery via generative AI! Love how Flagship Pioneering (where I began my VC journey during my PhD) drives disruption like ARK Invest . Listen:

As AI agents commoditize drug discovery, proprietary data will be key to creating value. Read about it in ARK Invest's newsletter! ark-invest.com/newsletters/is…

New Biology equals New Revenue Illumina's PromoterAI: Unlocking Hidden Genetic Insights with AI Illumina’s $ILMN launch of PromoterAI demonstrates the transformative impact of AI on personalized medicine. By pinpointing promoter variants affecting gene expression—linked to 6%

x.com/i/article/1929…

Biotech often faces a mismatch between scientific progress and capital cycles. In a Fireside Chat, Generate:Biomedicines's CEO says monetizing near-term assets, like its anti-TSLP antibody, while scaling long-term platform development can reduce investor reliance and fuel innovation.